Sun Pharmaceutical Industries Ltd (SUN.NS)
12 Feb 2016
* Dilip Shanghvi says not looking for external assets as of now Further company coverage:
MUMBAI, Feb 12 India's largest drugmaker, Sun Pharmaceutical Industries Ltd, reported a third-quarter net profit outpacing analysts' estimates, lifting its shares up as much as 6.5 percent.
** India's Sun Pharmaceutical Industries Ltd falls as much as 3.37 pct
** Shares in India's Sun Pharmaceuticals Industries Ltd rose as much as 3.4 percent on Wednesday morning to a high of 790 rupees
** Announcement allays capital allocation concerns of investors - Analysts
** Indian drug makers attract short positions in derivatives even after being oversold
** Says new disclosure of Halol being classified as official action initiated (OAI) flag increases the chances of a warning letter
** Sun Pharmaceutical Industries slumps 5.3 pct, Dr.Reddy's Laboratories down 1.7 pct and Lupin falls 1.6 pct
** Traders cite optimism tied to launch of Keveyis drug in the U.S. market by unit Taro Pharmaceutical Industries
MUMBAI Sun Pharmaceutical Industries Ltd, India's largest drugmaker by sales, said it is looking to divest a manufacturing plant in Ireland as it tries to control costs that have spiralled since it bought Ranbaxy Laboratories Ltd.